MASSDEVICE ON CALL — Healthcare industry giant Baxter (NYSE:BAX) is moving its corporate headquarters to Massachusetts in a sneaky plot dubbed "Project Tiger" by Bay State economic and business officials, according to a Boston Business Journal report.
Baxter, which is preparing to split its pharmaceutical division from its medical products division, is reportedly looking for 150,000-200,000 square feet of space in Cambridge, hoping to tap into the local talent, anonymous sources told the Journal. It’s not clear which half of the post-split company will head to Massachusetts.
Baxter, currently headquartered in Deerfield, Ill., declined to comment on the rumors, but the move could bring "hundreds, if not thousands, of jobs" to the area, according to the report.
Top Republican lawmakers are profiting from the Medtronic-Covidien deal
House Speaker John Boehner and Ways & Means Committee Chairman Dave Camp both reported sales of Covidien (NYSE:COV) stock within a few days of the announcement of the company’s $43 billion acquisition by Medtronic (NYSE:MDT).
Read more
What does 4.5 million stolen medical records really cost?
Hacked healthcare group Community Health Systems may have hundreds of thousands in fines and settlements on its hands after reported that some 4.5 million patient medical records were stolen by cybercriminals.
Read more
Medical journal draws ire after going commercial
The journal Experimental & Clinical Cardiology, once a peer-reviewed and respected medical journal, is now selling "journal" credibility to any entity willing to pay for publication.
Read more
Fewer blood transfusions means pressure for industry
Blood banks and other blood management groups are facing major belt-tightening as advances in medicine mean fewer patients need transfusions.
Read more
